Literature DB >> 16313497

Melatonin protects against lipopolysaccharide-induced intra-uterine fetal death and growth retardation in mice.

Yuan-Hua Chen1, De-Xiang Xu, Jian-Ping Wang, Hua Wang, Ling-Zhen Wei, Mei-Fang Sun, Wei Wei.   

Abstract

Lipopolysaccharide (LPS) has been associated with adverse developmental outcomes, including intra-uterine fetal death (IUFD) and intra-uterine growth retardation (IUGR). However, the exact mechanism for LPS-induced IUFD and IURD remains unclear. LPS stimulates macrophages to generate reactive oxygen species (ROS). Therefore, we hypothesize that ROS may be involved in LPS-induced IUFD and IURD. Melatonin is a powerful endogenous antioxidant. In this study, we investigated the protective effects of melatonin on LPS-induced IUFD and IURD in ICR mice. All pregnant mice except controls received an intraperitoneal (75 microg/kg, i.p.) injection of LPS on gestational day (gd) 15-17. The experiment was carried out in two different modes. In mode A, the pregnant mice received two doses of melatonin within 24 hr, one (5 or 10 mg/kg) injected immediately after LPS and the other (5 or 10 mg/kg) injected at 3 hr after LPS. In mode B, the pregnant mice were pretreated with 10 mg/kg of melatonin 18 hr before LPS and then received two doses of melatonin in 24 hr, one (10 mg/kg) injected immediately after LPS and the other (10 mg/kg) injected 3 hr after LPS. The number of live fetuses, dead fetuses and resorption sites were counted on gd 18. Live fetuses in each litter were weighed. Crown-rump and tail lengths were examined and skeletal development was evaluated. Results showed that post-treatments with melatonin significantly attenuated LPS-induced IUFD in a dose-dependent manner. Surprisingly, pre- plus post-treatments with melatonin almost blocked LPS-induced IUFD. In addition, both post-treatments and pre- plus post-treatments with melatonin significantly alleviated LPS-induced decreases in crown-rump and tail lengths and reversed LPS-induced skeletal developmental retardation. However, melatonin had little effect on LPS-induced decrease in fetal weight. Furthermore, pre- plus post-treatments with melatonin significantly attenuated LPS-induced lipid peroxidation in maternal liver. These results indicate that melatonin protects against LPS-induced IURD and IUGR via counteracting LPS-induced oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16313497     DOI: 10.1111/j.1600-079X.2005.00274.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  20 in total

1.  Treatment with melatonin after onset of experimental uveitis attenuates ocular inflammation.

Authors:  P H Sande; D Dorfman; D C Fernandez; M Chianelli; A P Domínguez Rubio; A M Franchi; D M Silberman; R E Rosenstein; D A Sáenz
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

2.  The Combination of Zinc and Melatonin Enhanced Neuroprotection and Attenuated Neuropathy in Oxaliplatin-Induced Neurotoxicity.

Authors:  Mayyadah Ali; Tavga Aziz
Journal:  Drug Des Devel Ther       Date:  2022-10-04       Impact factor: 4.319

Review 3.  Bench to cribside: the path for developing a neuroprotectant.

Authors:  Nelina Ramanantsoa; Bobbi Fleiss; Myriam Bouslama; Boris Matrot; Leslie Schwendimann; Charles Cohen-Salmon; Pierre Gressens; Jorge Gallego
Journal:  Transl Stroke Res       Date:  2012-12-21       Impact factor: 6.829

4.  Rapid Communication: Maternal melatonin implants improve fetal oxygen supply and body weight at term in sheep pregnancies.

Authors:  Francisco Sales; Oscar A Peralta; Eileen Narbona; Sue McCoard; Antonio González-Bulnes; Victor H Parraguez
Journal:  J Anim Sci       Date:  2019-02-01       Impact factor: 3.159

Review 5.  Melatonin and the skeleton.

Authors:  A K Amstrup; T Sikjaer; L Mosekilde; L Rejnmark
Journal:  Osteoporos Int       Date:  2013-05-29       Impact factor: 4.507

6.  Melatonin Ameliorates LPS-Induced Testicular Nitro-oxidative Stress (iNOS/TNFα) and Inflammation (NF-kB/COX-2) via Modulation of SIRT-1.

Authors:  Jitendra Kumar; Chandana Haldar; Rakesh Verma
Journal:  Reprod Sci       Date:  2021-04-30       Impact factor: 3.060

7.  RO4929097 regulates RANKL-induced osteoclast formation and LPS-mediated bone resorption.

Authors:  Tao Huang; Congyun Zhao; Yi Zhao; Yuan Zhou; Lei Wang; Donghua Hang
Journal:  Aging (Albany NY)       Date:  2021-05-02       Impact factor: 5.682

Review 8.  The fetal origins of the metabolic syndrome: can we intervene?

Authors:  Noelle Ma; Daniel B Hardy
Journal:  J Pregnancy       Date:  2012-09-17

Review 9.  Next generation strategies for preventing preterm birth.

Authors:  Hannah C Zierden; Rachel L Shapiro; Kevin DeLong; Davell M Carter; Laura M Ensign
Journal:  Adv Drug Deliv Rev       Date:  2021-04-23       Impact factor: 17.873

Review 10.  Fetal Neuroprotective Strategies: Therapeutic Agents and Their Underlying Synaptic Pathways.

Authors:  Nada A Elsayed; Theresa M Boyer; Irina Burd
Journal:  Front Synaptic Neurosci       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.